Filing Details
- Accession Number:
- 0001181431-11-036389
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-13 19:21:58
- Reporting Period:
- 2011-06-09
- Filing Date:
- 2011-06-13
- Accepted Time:
- 2011-06-13 19:21:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013702 | Richard King | C/O Acelrx Pharmaceuticals, Inc. 575 Chesapeake Drive Redwood City CA 94063 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-06-09 | 3,500 | $4.56 | 126,957 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $4.54-$4.58, inclusive. The reporting person undertakes to provide to Acelrx Pharmaceuticals, Inc., any security holder of Acelrx Pharmaceuticals, Inc., or the staff of the Securities and Exchange Comission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
